Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial

Peer Review reports

Original Submission
12 Mar 2023	Submitted	Original manuscript
9 Jul 2023	Reviewed	Reviewer Report
11 Aug 2023	Reviewed	Reviewer Report
24 Aug 2023	Author responded	Author comments - Mohammadreza Shalbafan
28 Aug 2023	Author responded	Author comments - Mohammadreza Shalbafan
Resubmission - Version 2
24 Aug 2023	Submitted	Manuscript version 2
2 Sep 2023	Reviewed	Reviewer Report
12 Sep 2023	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
12 Sep 2023	Editorially accepted
21 Sep 2023	Article published	10.1186/s12888-023-05189-7

Back to article page